Cite
HARVARD Citation
Casey, K. et al. (2018). Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE. Lupus science & medicine. 5 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Casey, K. et al. (2018). Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE. Lupus science & medicine. 5 (1), p. . [Online].